WASHINGTON (AP) -- A health panel wants to ease the limits on an acne drug.
Health advisers are urging slightly more flexibility in rules designed to prevent pregnancies among women taking the acne drug accutane, which has caused birth defects. That's even though women taking the drug are still getting pregnant.
F-D-A advisers decided that minor changes would ease access to the drug, without further increasing those troubling pregnancies.
Women taking accutane are supposed to pledge not to become pregnant. But administrators say there were 122 pregnancies in the i-Pledge program's first year.